107 related articles for article (PubMed ID: 9873696)
1. Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
Keenan RM; Miller WH; Lago MA; Ali FE; Bondinell WE; Callahan JF; Calvo RR; Cousins RD; Hwang SM; Jakas DR; Ku TW; Kwon C; Nguyen TT; Reader VA; Rieman DJ; Ross ST; Takata DT; Uzinskas IN; Yuan CC; Smith BR
Bioorg Med Chem Lett; 1998 Nov; 8(22):3165-70. PubMed ID: 9873696
[TBL] [Abstract][Full Text] [Related]
2. Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model.
Keenan RM; Lago MA; Miller WH; Ali FE; Cousins RD; Hall LB; Hwang SM; Jakas DR; Kwon C; Louden C; Nguyen TT; Ohlstein EH; Rieman DJ; Ross ST; Samanen JM; Smith BR; Stadel J; Takata DT; Vickery L; Yuan CC; Yue TL
Bioorg Med Chem Lett; 1998 Nov; 8(22):3171-6. PubMed ID: 9873697
[TBL] [Abstract][Full Text] [Related]
3. Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics.
Keenan RM; Miller WH; Barton LS; Bondinell WE; Cousins RD; Eppley DF; Hwang SM; Kwon C; Lago MA; Nguyen TT; Smith BR; Uzinskas IN; Yuan CC
Bioorg Med Chem Lett; 1999 Jul; 9(13):1801-6. PubMed ID: 10406645
[TBL] [Abstract][Full Text] [Related]
4. Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.
Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Keldenich J; Lustig K; Tsujishita H; Gerdes C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6151-4. PubMed ID: 17910915
[TBL] [Abstract][Full Text] [Related]
5. Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
Meissner RS; Perkins JJ; Duong LT; Hartman GD; Hoffman WF; Huff JR; Ihle NC; Leu CT; Nagy RM; Naylor-Olsen A; Rodan GA; Rodan SB; Whitman DB; Wesolowski GA; Duggan ME
Bioorg Med Chem Lett; 2002 Jan; 12(1):25-9. PubMed ID: 11738566
[TBL] [Abstract][Full Text] [Related]
6. Novel potent and selective alphavbeta3/alphavbeta5 integrin dual antagonists with reduced binding affinity for human serum albumin.
Raboisson P; Manthey CL; Chaikin M; Lattanze J; Crysler C; Leonard K; Pan W; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2006 Jul; 41(7):847-61. PubMed ID: 16697080
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
Keenan RM; Miller WH; Kwon C; Ali FE; Callahan JF; Calvo RR; Hwang SM; Kopple KD; Peishoff CE; Samanen JM; Wong AS; Yuan CK; Huffman WF
J Med Chem; 1997 Jul; 40(15):2289-92. PubMed ID: 9240343
[No Abstract] [Full Text] [Related]
8. Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements.
Coleman PJ; Brashear KM; Hunt CA; Hoffman WF; Hutchinson JH; Breslin MJ; McVean CA; Askew BC; Hartman GD; Rodan SB; Rodan GA; Leu CT; Prueksaritanont T; Fernandez-Metzler C; Ma B; Libby LA; Merkle KM; Stump GL; Wallace AA; Lynch JJ; Lynch R; Duggan ME
Bioorg Med Chem Lett; 2002 Jan; 12(1):31-4. PubMed ID: 11738567
[TBL] [Abstract][Full Text] [Related]
9. Non-peptide alpha(v)beta(3) antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl beta-amino acids as aspartic acid replacements.
Brashear KM; Hunt CA; Kucer BT; Duggan ME; Hartman GD; Rodan GA; Rodan SB; Leu CT; Prueksaritanont T; Fernandez-Metzler C; Barrish A; Homnick CF; Hutchinson JH; Coleman PJ
Bioorg Med Chem Lett; 2002 Dec; 12(23):3483-6. PubMed ID: 12419389
[TBL] [Abstract][Full Text] [Related]
10. Isoxazolines as potent antagonists of the integrin alpha(v)beta(3).
Pitts WJ; Wityak J; Smallheer JM; Tobin AE; Jetter JW; Buynitsky JS; Harlow PP; Solomon KA; Corjay MH; Mousa SA; Wexler RR; Jadhav PK
J Med Chem; 2000 Jan; 43(1):27-40. PubMed ID: 10633036
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamides.
Hashimoto K; Tatsuta M; Kataoka M; Yasoshima K; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta JB; Urbahns K
Bioorg Med Chem Lett; 2005 Feb; 15(3):799-803. PubMed ID: 15664860
[TBL] [Abstract][Full Text] [Related]
12. Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists.
Sulyok GA; Gibson C; Goodman SL; Hölzemann G; Wiesner M; Kessler H
J Med Chem; 2001 Jun; 44(12):1938-50. PubMed ID: 11384239
[TBL] [Abstract][Full Text] [Related]
13. Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists.
Keenan RM; Callahan JF; Samanen JM; Bondinell WE; Calvo RR; Chen L; DeBrosse C; Eggleston DS; Haltiwanger RC; Hwang SM; Jakas DR; Ku TW; Miller WH; Newlander KA; Nichols A; Parker MF; Southhall LS; Uzinskas I; Vasko-Moser JA; Venslavsky JW; Wong AS; Huffman WF
J Med Chem; 1999 Feb; 42(4):545-59. PubMed ID: 10052962
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective alpha(V)beta(3) antagonists.
Kling A; Backfisch G; Delzer J; Geneste H; Graef C; Holzenkamp U; Hornberger W; Lange UE; Lauterbach A; Mack H; Seitz W; Subkowski T
Bioorg Med Chem Lett; 2002 Feb; 12(3):441-6. PubMed ID: 11814816
[TBL] [Abstract][Full Text] [Related]
15. Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.
Miller WH; Bondinell WE; Cousins RD; Erhard KF; Jakas DR; Keenan RM; Ku TW; Newlander KA; Ross ST; Haltiwanger RC; Bradbeer J; Drake FH; Gowen M; Hoffman SJ; Hwang SM; James IE; Lark MW; Lechowska B; Rieman DJ; Stroup GB; Vasko-Moser JA; Zembryki DL; Azzarano LM; Adams PC; Huffman WF
Bioorg Med Chem Lett; 1999 Jul; 9(13):1807-12. PubMed ID: 10406646
[TBL] [Abstract][Full Text] [Related]
16. Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides.
Li Y; Kataoka M; Tatsuta M; Yasoshima K; Yura T; Urbahns K; Kiba A; Yamamoto N; Gupta JB; Hashimoto K
Bioorg Med Chem Lett; 2005 Feb; 15(3):805-7. PubMed ID: 15664861
[TBL] [Abstract][Full Text] [Related]
17. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
[TBL] [Abstract][Full Text] [Related]
18. Substituted benzocyloheptenes as potent and selective alpha(v) integrin antagonists.
Perron-Sierra F; Saint Dizier D; Bertrand M; Genton A; Tucker GC; Casara P
Bioorg Med Chem Lett; 2002 Nov; 12(22):3291-6. PubMed ID: 12392735
[TBL] [Abstract][Full Text] [Related]
19. Biphenyls as potent vitronectin receptor antagonists.
Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Gerdes C
Bioorg Med Chem Lett; 2002 Jan; 12(2):205-8. PubMed ID: 11755355
[TBL] [Abstract][Full Text] [Related]
20. Novel malonamide derivatives as alpha v beta 3 antagonists. Syntheses and evaluation of 3-(3-indolin-1-yl-3-oxopropanoyl)aminopropanoic acids on vitronectin interaction with alpha v beta 3.
Nagashima S; Akamatsu S; Kawaminami E; Kawazoe S; Ogami T; Matsumoto Y; Okada M; Suzuki KI; Tsukamoto SI
Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1420-32. PubMed ID: 11724232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
